Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Payne

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Journal of Biomedical Optics|February 2, 2011
Light penetration in the human prostate: a whole prostate clinical study at 763 nmCaroline M Moore, C Alexander Mosse, Clare Allen, et al.
World Journal of Urology|April 22, 2016
The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UKDerek J Rosario, Patrick Davey, James Green, et al.
International Journal of Clinical Practice|December 1, 2020
Management of newly diagnosed metastatic hormone-sensitive prostate cancer: A survey of UK Uro-oncologistsAmit Bahl, Simon Crabb, Dan Ford, et al.
Journal of Cancer Policy|June 20, 2022
Practicalities, challenges and solutions to delivering a national organisational survey of cancer service and processes: Lessons from the National Prostate Cancer AuditJoanna Dodkins, Melanie Morris, Julie Nossiter, et al.
The Journal of Cardiovascular Nursing|April 4, 2014
Development and testing of the feasibility and acceptability of a tailored dietary intervention in patients with heart failureSeongkum Heo, Debra K Moser, Terry A Lennie, et al.
European Urology Oncology|June 28, 2023
Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the "Real World"? A Systematic ReviewJoanna Dodkins, Julie Nossiter, Adrian Cook, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 7, 2005
[Reevaluation of MAB therapy and progress of endocrine therapy]Laurence Klotz, Heather Payne, David Gillatt, et al.
Human Vaccines & Immunotherapeutics|June 22, 2022
Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant womenStuart J Moat, Sharon Hillier, Sikha de Souza, et al.
Urologic Oncology|November 19, 2013
Second-line chemotherapy for advanced bladder cancer: a survey of current UK practiceBenjamin W Lamb, Nikhil Vasdev, Rozh T Jalil, et al.
The Lancet. Oncology|March 7, 2021
Public reporting of outcomes in radiation oncology: the National Prostate Cancer AuditAjay Aggarwal, Julie Nossiter, Matthew Parry, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Journal of Biomedical Optics|February 2, 2011
Light penetration in the human prostate: a whole prostate clinical study at 763 nmCaroline M Moore, C Alexander Mosse, Clare Allen, et al.
World Journal of Urology|April 22, 2016
The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UKDerek J Rosario, Patrick Davey, James Green, et al.
International Journal of Clinical Practice|December 1, 2020
Management of newly diagnosed metastatic hormone-sensitive prostate cancer: A survey of UK Uro-oncologistsAmit Bahl, Simon Crabb, Dan Ford, et al.
Journal of Cancer Policy|June 20, 2022
Practicalities, challenges and solutions to delivering a national organisational survey of cancer service and processes: Lessons from the National Prostate Cancer AuditJoanna Dodkins, Melanie Morris, Julie Nossiter, et al.
The Journal of Cardiovascular Nursing|April 4, 2014
Development and testing of the feasibility and acceptability of a tailored dietary intervention in patients with heart failureSeongkum Heo, Debra K Moser, Terry A Lennie, et al.
European Urology Oncology|June 28, 2023
Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the "Real World"? A Systematic ReviewJoanna Dodkins, Julie Nossiter, Adrian Cook, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 7, 2005
[Reevaluation of MAB therapy and progress of endocrine therapy]Laurence Klotz, Heather Payne, David Gillatt, et al.
Human Vaccines & Immunotherapeutics|June 22, 2022
Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant womenStuart J Moat, Sharon Hillier, Sikha de Souza, et al.
Urologic Oncology|November 19, 2013
Second-line chemotherapy for advanced bladder cancer: a survey of current UK practiceBenjamin W Lamb, Nikhil Vasdev, Rozh T Jalil, et al.
The Lancet. Oncology|March 7, 2021
Public reporting of outcomes in radiation oncology: the National Prostate Cancer AuditAjay Aggarwal, Julie Nossiter, Matthew Parry, et al.
Pageof 12